IL33 and neoplasm: IL-33 can regulate the mammalian target of rapamycin through the p38 MAPK pathway to induce facilitative glucose transporter 1, activate the uptake of glucose by cells, and complete oxidative phosphorylation in cells to obtain ATP, providing energy for the migration, invasion, and development of tumor cells (82).